Companies /Healthcare
Moderna Inc
NASDAQ: MRNA Biotechnology
$248.69
▼ $2.14 (−0.85%) today
Markets closed · 8:57pm ET

Moderna (MRNA) Earnings History & Trends

EPS and revenue vs. Street estimates · SEC filings
100%
EPS beat rate
+40.93%
Avg. EPS surprise
Consecutive EPS beats
MRNA vs Market · 30-day return after each reportMRNAS&P 500
0%+60%+120%+180%+2.9%+6.7%Q1 25−12.9%+3.5%Q2 25+16.1%+1.9%Q3 25+24.1%−3.0%Q4 25+8.1%+4.7%Q1 26+181.4%+2.0%Q2 26
0%+60%+120%+180%Q1 25Q3 25Q1 26
MRNA EPS Trend · estimate vs actualEstimateActual
$-4$-2$0$-3.18$-2.52Q1 25$-2.97$-2.13Q2 25$-2.18$-0.51Q3 25$-2.60$-2.11Q4 25$-3.88$-3.40Q1 26$-1.97$-1.97Q2 26$-1.28$0.38Q3 26
$-4$-2$0Q1 25Q3 25Q1 26Q3 26
MRNA Revenue Trend · estimate vs actualEstimateActual
$0$400.0M$800.0M$1.2B$115.3M$108.0MQ1 25$113.0M$142.0MQ2 25$869.9M$1.0BQ3 25$623.9M$678.0MQ4 25$236.4M$389.0MQ1 26$891.3M$1.3BQ3 26
$0$400.0M$800.0M$1.2BQ1 25Q3 25Q1 26

How Often Does Moderna Beat Earnings Estimates?

Moderna beat EPS estimates in 7 of its last 7 reported quarters, and has beaten 7 quarters in a row.

MRNA quarterly earnings per share and revenue versus Street estimates
Quarter EPS · est. Surprise Revenue · est. Surprise
Q3 2026 $0.38 est. $-1.28 +129.62% $1.3B est. $891.3M +47.31%
Q2 2026 $-1.97 est. $-1.97 +0.00% $145.0M —
Q1 2026 $-3.40 est. $-3.88 +12.37% $389.0M est. $236.4M +64.58%
Q4 2025 $-2.11 est. $-2.60 +18.88% $678.0M est. $623.9M +8.67%
Q3 2025 $-0.51 est. $-2.18 +76.60% $1.0B est. $869.9M +16.80%
Q2 2025 $-2.13 est. $-2.97 +28.34% $142.0M est. $113.0M +25.71%
Q1 2025 $-2.52 est. $-3.18 +20.69% $108.0M est. $115.3M −6.35%

Figures from SEC filings and company reports. Not investment advice.